Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Current Drug Targets|March 9, 2016
Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of CancerJorg B Engel, Hans-Rudolf Tinneberg, Ferenc G Rick, et al.
Oncotarget|September 4, 2012
Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancersRoberto Perez, Andrew V Schally, Irving Vidaurre, et al.
World Journal of Gastroenterology|May 31, 2014
Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectivesFlorian Hohla, Thomas Winder, Richard Greil, et al.
Peptides|June 16, 2009
Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162Andrea Treszl, Andrew V Schally, Stephan Seitz, et al.
Oncoscience|January 17, 2015
Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical studyRoberto Perez, Andrew V Schally, Petra Popovics, et al.
The Prostate|January 3, 2013
Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasiaFerenc G Rick, Andrew V Schally, Norman L Block, et al.
Oncotarget|March 23, 2013
Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormoneMiklos Jaszberenyi, Andrew V Schally, Norman L Block, et al.
Anti-Cancer Drugs|August 29, 2012
Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-IIKaroly Szepeshazi, Andrew V Schally, Ferenc G Rick, et al.
The Prostate|July 29, 2011
Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteinsAnton Stangelberger, Andrew V Schally, Ferenc G Rick, et al.
Aging|December 6, 2012
Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's diseaseMiklos Jaszberenyi, Ferenc G Rick, Luca Szalontay, et al.
Pageof 6